Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2288]
News [5263]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
NICE recommends lenvatinib for differentiated thyroid cancer
NICE recommends lenvatinib for differentiated thyroid cancer
Cutting off cervical cancer's fuel supply stymies tumours
Cutting off cervical cancer's fuel supply stymies tumours
A gene that increases the risk of pancreatic cancer controls inflammation in normal tissue
A gene that increases the risk of pancreatic cancer controls inflammation in normal tissue
Results of immunotherapy to treat aggressive colon tumours in mouse models
Results of immunotherapy to treat aggressive colon tumours in mouse models
Selenium enzyme shows promise as cancer therapy
Selenium enzyme shows promise as cancer therapy
Denosumab non-inferior versus zoledronic acid in delaying time to first on-study skeletal-related event
Denosumab non-inferior versus zoledronic acid in delaying time to first on-study skeletal-related event
Nivolumab immunotherapy safe, feasible during chemoradiation for advanced head and neck cancer
Nivolumab immunotherapy safe, feasible during chemoradiation for advanced head and neck cancer
Phase II trial shows activity of durvalumab in recurrent/metastatic head and neck cancer
Phase II trial shows activity of durvalumab in recurrent/metastatic head and neck cancer
Cabozantinib shows promise as first line treatment for differentiated thyroid cancer
Cabozantinib shows promise as first line treatment for differentiated thyroid cancer
Novel oncolytic virus shows promise as brain tumour immunotherapy
Novel oncolytic virus shows promise as brain tumour immunotherapy

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation